Who Just RaisedHealth Care · Canton, SDNew
Immuno Cancer Biotherapeutics, Inc.
Immuno Cancer Biotherapeutics, Inc. is a biotechnology company based in Canton, South Dakota. In a Form D filed with the SEC on October 15, 2026, it reported raising $75,000 from 3 investors as part of an offering of indefinite size. The first sale in the offering took place on October 9, 2026.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
- Open-ended round. The offering has no stated size limit.
$75K raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 15, 2026 | $75K | Open | 3 |
Lead score
50 out of 100
filed this week first raise ever still raising young company
Outreach kit
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the first round, Immuno Cancer Biotherapeutics
Hi there, Congrats on Immuno Cancer Biotherapeutics's first outside round. I saw the $75K raise in your SEC filing on Oct 15, and that the round is still open. Teams that have just raised for the first time usually start looking at [what you do] soon after, and that's what we help with: [one line on the result you deliver]. Would a 15-minute call next week be useful? Happy to share what similar companies did in their first months after raising. [Your name]
LinkedIn note
Congrats on Immuno Cancer Biotherapeutics's first outside round. Saw the $75K raise in your Form D. I work with [who you help] on [what you do] right after a round. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I'm calling because Immuno Cancer Biotherapeutics just filed a $75K raise with the SEC. Teams that have just raised for the first time often need [what you do], so I wanted to ask who looks after that at Immuno Cancer Biotherapeutics.
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company
Saved to your dashboard pipeline, with a badge in Explore.
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $75,000
- Offering size
- Indefinite
- Investors so far
- 3
- First sale
- October 9, 2026
- Securities offered
- Other
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Canton, South Dakota
- Incorporated
- Delaware, 2024
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $75,000 | Indefinite | 3 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Similar raises
Norman Retirement, LLC
Aberdeen, SD · filed Sep 10First Form D
Ensho Therapeutics, Inc.
Woodcliff Lake, NJ · filed Oct 155th Form D since 2024Still raising
Light Wave Ownership Path, LLC
Raleigh, NC · filed Oct 1512th Form D since 2019
Kaigene, Inc.
Rockville, MD · filed Oct 142nd Form D since 2022Still raising